Citations

Bacterial Toxin Research Citations

We’ve gathered published citations for the past many years so that researchers can easily review at their convenience from among the thousands of published articles, how they might use our products in detail or apply these ideas to their own novel thinking for new research.

Search through, read and share our information rich citations below!

Contact us with any questions.

4918 total record number 290 records this year

To narrow your search, use one or more of the following search menus below.

To search by keyword, you may search by the cell/animal/assay/protein/research or publication
Page 28 out of 492
4918 citations found

Direct interrogation of context-dependent GPCR activity with a universal biosensor platform

Janicot, R;Maziarz, M;Park, JC;Luebbers, A;Green, E;Zhao, J;Philibert, C;Zhang, H;Layne, MD;Wu, JC;Garcia-Marcos, M;

Product: Pertussis Toxin from B. pertussis (in Glycerol)

Gasdermin D in macrophages drives orchitis by regulating inflammation and antigen presentation processes

Ma, C;Huang, J;Jiang, Y;Liu, L;Wang, N;Huang, S;Li, H;Zhang, X;Wen, S;Wang, B;Yang, S;

Product: Pertussis Toxin from B. pertussis, Lyophilized in Buffer

  • Induction of experimental autoimmune orchitis (EAO)

    Age-matched male Gsdmdfl/flCx3cr1-cre and Cx3cr1-cre mice were used to induce EAO, as described previously (Nicolas et al, 2017). First, the testicular homogenate (TH) was obtained from decapsulated testes of adult syngeneic mice and homogenized in an equal volume of sterile PBS. Second, TH was mixed with incomplete Freund’s adjuvant (IFA; Sigma-Aldrich, F5506) containing 1 mg/ml Mycobacterium tuberculosis (BD, 231141) in 1:1 ratio. Finally, the mice were immunized thrice every 14 days with the mixture, followed by an intraperitoneal injection of 100 ng pertussis toxin (List Biological Laboratories, lot#180) in 100 μl PBS. Each animal was immunized dorsally at four sites near the popliteal lymph nodes in a total volume of 200 μl. The testes were collected for further analysis 50 days after the first immunization.

    Product #179A – Pertussis Toxin from B. pertussis (in Glycerol)

Product: Anti-Cholera Toxin B Subunit (Goat)

  • Cholera Toxin B (CTB) Purified choleragenoid, the B subunit of cholera toxin List Biological, goat polyclonal, cat. #703, lot #7032A9, RRID: AB_10013220 1:10,000 Chicken Ovalbumin Upstream Promoter Transcription FactorInteracting Protein 2 (Ctip2) Fusion protein corresponding to Human Ctip2. Abcam, rat polyclonal, cat. #ab18465, lot # GR322373-7, RRID: AB_2064130 1

Product: Pertussis Toxin from B. pertussis, Lyophilized (Salt-Free)

  • Bordetella pertussis toxin (List Biological Laboratories, Inc. #181) the day of immunization and again 2 days later. Motor scores reflecting progressive ascending paralysis were assessed daily using the following scoring system: 0—no disease, 0.5—reduced tail tone, 1—loss of tail tone, 1.5—limp tail and ataxia, 2

Product: Pertussis Toxin from B. pertussis, Lyophilized in Buffer

  • USA). MOG35-55 (2 mg/mL in TDW) was vigorously mixed with the same volume of CFA using a homogenizer (Qiagen). The peptide emulsion was injected subcutaneously at 200 ?g per mouse. Pertussis toxin (PTX; List Biological Labs, Campbell, CA, USA) was prepared in PBS and intraperitoneally injected at 400 ng per mouse, at 2 hr and 24 hr post administration of the CFA emulsion. For the prophylactic treatment, the nanoparticles were administered subcutaneously at 1 mg of PN and 6 ?g of dexamethasone per mouse at 1 and 2 weeks before injection with the MOG/CFA emulsion. For the therapeutic treatment, various nanoparticle

Product: Cholera Toxin (AZIDE-FREE) from Vibrio cholerae

  • Choleratoxin List Biological Laboratories (Campbell, CA, USA) Glucose Sigma

Product: ULTRA PURE LPS from Escherichia coli O111:B4

  • mal-Free Recombinant Murine IL-4 PeproTech AF-214-14 Animal-Free Recombinant Murine IL-10 PeproTech AF-210-10 ULTRA PURE LPS from Escherichia coli O111:B4 List Biological Laboratories 421

Product: Cholera Toxin B Subunit (Choleragenoid) from Vibrio cholerae in Low Salt

  • ts, Tujunga CA) on a homeothermic hea+ng blanket to maintain body temperature of 370 C. The dorsal brainstem was exposed via blunt dissec+on and, following removal of the meningeal membrane, the vagal trigone was exposed. Then, five microinjec+ons of Cholera Toxin B (CTB; List Labs, Campbell, CA, 0.5% in dis+lled water; 60nl per injec+on) were made using a glass pipeEe aEached to a Picospritzer (Toohey Co., Fairfield NJ) into the rostrocaudal extent of the DMV at co-ordinates (in mm) rostro-caudal 0.0-0.6mm from calamus scriptorius, medio-lateral +0.3-0.4 from the midline; dorso-ventral -0.6-0.65 from the surface of the brainstem Injec+ons were made

??????????????????

???, ;

Product: Cholera Toxin B Subunit (Choleragenoid) from Vibrio cholerae in Low Salt

  • ??????????? ?????? 1% Fluorogold(FG; Fluorochrome, Englewood, CO, USA),??? 0.1 M PB ????? 1% ???? B ??????(CTb; List Biological

Product: Pertussis Toxin from B. pertussis, Lyophilized in Buffer

  • d 2 post-immunisation, mice received an intraperitoneal injection of 200 ng pertussis toxin in 200 ?L PBS (List Biological Laboratories, #179A). The mice were monitored and scored daily for EAE symp